Musculoskeletal, Neural, and Ocular Physiology Commons^™

Joint-Specific Changes In Locomotor Complexity In The Absence Of Muscle Atrophy Following Incomplete Spinal Cord Injury, Brian K. Hillen, Gary T. Yamaguchi, James J. Abbas, Ranu Jung

Department of Biomedical Engineering Faculty Publications

ackground

Following incomplete spinal cord injury (iSCI), descending drive is impaired, possibly leading to a decrease in the complexity of gait. To test the hypothesis that iSCI impairs gait coordination and decreases locomotor complexity, we collected 3D joint angle kinematics and muscle parameters of rats with a sham or an incomplete spinal cord injury.

Methods

12 adult, female, Long-Evans rats, 6 sham and 6 mild-moderate T8 iSCI, were tested 4 weeks following injury. The Basso Beattie Bresnahan locomotor score was used to verify injury severity. Animals had reflective markers placed on the bony prominences of their limb joints and were …

Test-Retest Reliability For Voluntary And Evoked Measures Of Peak Torque, Electromechanical Delay, And Rate Of Torque Development In Older Men., Nathaniel D.M. Jenkins

Department of Nutrition and Health Sciences: Dissertations, Theses, and Student Research

The purpose of this study was to examine the test-retest reliability for peak torque (PT), rates of torque development (RTD), and electromechanical delay (EMD) calculated during voluntary and evoked muscle actions in men ages 65 and older. Fifteen older men (mean ± standard deviation (SD) age = 72.3 ± 7.3 years) completed 3 evoked and 3 voluntary isometric muscle actions of the leg extensors during two visits separated by 48 to 72 h. PT and EMD were calculated during voluntary and evoked muscle actions. RTD was quantified as the peak RTD, overall RTD, RTD in time intervals of 0-30 (RTD30), …

Antibiotic-Like Actions Of Vitamin D, Franklin D. Shuler Md, Phd, Josh Hendrix, Adam Short, Sammy Hodroge

Orthopaedics

Vitamin D is a secosteroid hormone that has expanding importance for a healthy lifestyle and disease prevention. A multitude of studies have highlighted that vitamin D acts not only in bone and calcium homeostasis but is critically important for human immunity. The discovery that the storage form of vitamin D (25-hydroxyvitamin D3) can be locally converted to the active form (1,25-hydroxyvitamin D3) in immune cells, epithelial cells and numerous other non-renal tissues highlights the importance of maintaining sufficient stores. When responding to a specific external stimulus, like bacterial invasion, intracrine synthesis of active vitamin D has the ability to regulate …

Optic Neuritis Due To Toxoplasmosis: First And Only Manifestation Of Newly Diagnosed Aids, Rajesh Kumar Md, Yehia Y. Mishriki Md

Department of Medicine

No abstract provided.

Bmp7 Gene Transfer Via Gold Nanoparticles Into Stroma Inhibits Corneal Fibrosis In Vivo, Ashish Tandon, Ajay Sharma, Jason T. Rodier, Alexander M. Klibanov, Frank G. Rieger, Rajiv R. Mohan

Pharmacy Faculty Articles and Research

This study examined the effects of BMP7 gene transfer on corneal wound healing and fibrosis inhibition in vivo using a rabbit model. Corneal haze in rabbits was produced with the excimer laser performing -9 diopters photorefractive keratectomy. BMP7 gene was introduced into rabbit keratocytes by polyethylimine-conjugated gold nanoparticles (PEI2- GNPs) transfection solution single 5-minute topical application on the eye. Corneal haze and ocular health in live animals was gauged with stereo- and slit-lamp biomicroscopy. The levels of fibrosis [a-smooth muscle actin (aSMA), F-actin and fibronectin], immune reaction (CD11b and F4/80), keratocyte apoptosis (TUNEL), calcification (alizarin red, vonKossa and osteocalcin), and …

Corneal Gene Therapy: Basic Science And Translational Perspective, Rajiv R. Mohan, Jason T. Rodier, Ajay Sharma

Pharmacy Faculty Articles and Research

Corneal blindness is the third leading cause of blindness worldwide. Gene therapy is an emerging technology for corneal blindness due to the accessibility and immune-privileged nature of the cornea, ease of vector administration and visual monitoring, and ability to perform frequent noninvasive corneal assessment. Vision restoration by gene therapy is contingent upon vector and mode of therapeutic gene introduction into targeted cells/tissues. Numerous efficacious vectors, delivery techniques, and approaches have evolved in last decade for developing gene-based interventions for corneal diseases. Maximizing the potential benefits of gene therapy requires efficient and sustained therapeutic gene expression in target cells, low toxicity, …